1. Home
  2. CHMI vs YARW Comparison

CHMI vs YARW Comparison

Compare CHMI & YARW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.90

Market Cap

108.3M

Sector

Real Estate

ML Signal

HOLD

Logo Yarrow Bioscience Inc. Common Stock

YARW

Yarrow Bioscience Inc. Common Stock

N/A

Current Price

$26.99

Market Cap

114.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHMI
YARW
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.3M
114.6M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
CHMI
YARW
Price
$2.90
$26.99
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
293.1K
32.2K
Earning Date
05-07-2026
N/A
Dividend Yield
15.09%
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$61.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$26.01
52 Week High
$3.04
$44.28

Technical Indicators

Market Signals
Indicator
CHMI
YARW
Relative Strength Index (RSI) 63.93 34.09
Support Level $2.55 $27.31
Resistance Level $2.98 $43.96
Average True Range (ATR) 0.04 3.84
MACD -0.02 -1.07
Stochastic Oscillator 6.25 12.69

Price Performance

Historical Comparison
CHMI
YARW

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About YARW Yarrow Bioscience Inc. Common Stock

Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.

Share on Social Networks: